NCT04470128View on ClinicalTrials.gov

A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonoscopy

PHASE2CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

December 28, 2020

Study Completion Date

January 30, 2021

Conditions

Analgesia

Interventions

DRUG

Stage I: HSK21542 0.5 μg/kg

intravenous injection

DRUG

Stage I: HSK21542 1 μg/kg

intravenous injection

DRUG

HSK21542 0.5 μg/kg

intravenous injection

DRUG

HSK21542 1 μg/kg

intravenous injection

DRUG

HSK21542 2 μg/kg

intravenous injection

DRUG

Placebo

intravenous injection

Trial Locations (1)

Unknown

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY

NCT04470128 - A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonoscopy | Biotech Hunter | Biotech Hunter